SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates FMTX, TRQ, SGFY

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates FMTX, TRQ, SGFY

NEW YORK, Sept. 19, 2022 (GLOBE NEWSWIRE) -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to:

Forma Therapeutics, Holdings Inc. (NASDAQ: FMTX)’s sale to Novo Nordisk for $20.00 per share in cash. If you are a Forma shareholder, click here to learn more about your rights and options.

Turquoise Hill Resources Ltd. (NYSE: TRQ)’s proposed sale to Rio Tinto for C$43 per share in cash. If you are a Turquoise Hill shareholder, click here to learn more about your rights and options.

Signify Health, Inc. (NYSE: SGFY)’s sale to CVS Health Corporation for $30.50 per share in cash. If you are a Signify Health shareholder, click here to learn more about your rights and options.

Shareholders are encouraged to contact the firm free of charge to discuss their legal rights and options. Please call Daniel Sadeh or Zachary Halper at (212) 763-0060 or email [email protected] or [email protected].

Halper Sadeh LLC represents investors all over the world who have fallen victim to securities fraud and corporate misconduct. Our attorneys have been instrumental in implementing corporate reforms and recovering millions of dollars on behalf of defrauded investors.

Attorney Advertising. Prior results do not guarantee a similar outcome.

Contact Information:
Halper Sadeh LLC
Daniel Sadeh, Esq.
Zachary Halper, Esq.
(212) 763-0060
[email protected]
[email protected]
https://www.halpersadeh.com